Investigations revealed that a French pharmaceutical company fell victim to a business e-mail impersonation scam by the syndicate in March 2020. The firm transferred more than $10 million for what ...
Ultragenyx Pharmaceutical RARE during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how ...
Q3 2024 Earnings Call Transcript November 4, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.38, expectations were $4.14. Operator: Good day. And welcome to ...
As the Canadian economy experiences a cooling labor market and anticipates further interest rate cuts by the Bank of Canada, financial markets are poised to navigate these shifts with cautious ...
The drugmaker posted revenue of $117.1 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $114.8 million. BioCryst expects full-year revenue in the range of ...